November 21, 2018

 

Cancer Immunotherapy for Non-Hodgkin's Lymphoma-Hope Medical Group

Disadvantages of Radiotherapy & Chemotherapy
Chemotherapy works by interrupting cell division in cells that are multiplying quickly. Since cancer cells reproduce at an abnormally fast rate, they are affected by chemotherapy. Several cycles are needed to catch more cells, since not all of them will be dividing on the day you get chemotherapy. Unfortunately, other cells in your body also reproduce quickly enough to be affected by the treatment. Hair follicles shut down, which means your hair either falls out or does not grow. The linings of the mouth, stomach, and intestines also contain cells that multiply rapidly. These cells are disrupted by chemotherapy, which can cause mouth sores, a "burned tongue" sensation, nausea, constipation, hemorrhoids, and diarrhea.
The disadvantage of radiotherapy is also the worry that the cancer will come back.

Non-surgical treatments
DC + CIK cells can effectively cure cancer.
Today, tumors can be detected early and removed with advanced surgery and treatment, but current therapies cannot prevent or eradicate cancer after metastatic spread to distant organs. The prognosis is very poor if Cancer spreads to the brain. As a shielded "sanctuary site," the brain may harbor cancer cells which resist current treatments and can develop into satellite tumors, known as metastases, long after chemo-, radiation, or immuno- therapies have been applied. The patient's situation can be managed in the clinic only for a few weeks or months before becoming fatal.
Our DC+CIK cancer treatment provides new hope for patients, through an innovative approach based on stem cells, the body's own natural mechanism for healing and regeneration.
Cytokine-induced killer (CIK) cells are important immune cells, and dendritic cells (DC) can be induced to be co-cultured with CD3 + CD56 + (NKT) phenotype main groups of T-killer cells (DCCIK). Immunotherapy in cancer patients showed a broad spectrum of killing tumor cells, its function and use of exogenous split-mediated tumor cell material, tumor-associated antigen-activated DC, CIK cells co-cultured cells different, is not major histocompatibility complex (MHC) restricted, and there is a strong anti-tumor immune activity. It also significantly reduces the immune tolerance of cancer patients, a decrease of T suppressor cells (Treg1 immunosuppression and effectively prevent the generation of autoimmune disease in patients.

In short, DC+CIK cells in the human body's own immune system enhance and rebuild its immune system, automatically identify and track tumor cells, and transmit this information to patients own immune cells, promoting their activation and proliferate to eliminate residual metastatic lesions, prevent spread and recurrence of cancer and enhance immunity. This improves the quality of life of patients, ultimately prolonging the patients life for years.



Non-Hodgkin's lymphoma, also called non-Hodgkin lymphoma, is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin's lymphoma, tumors develop from lymphocytes - a type of white blood cell.
 
Non-Hodgkin's lymphoma is more common than the other general type of lymphoma - Hodgkin lymphoma. Many different subtypes of non-Hodgkin's lymphoma exist. The most common non-Hodgkin's lymphoma subtypes include diffuse large B-cell lymphoma and follicular lymphoma.
 
Non-Hodgkin's lymphoma symptoms may include:
 
·         Swollen lymph nodes in your neck, armpits or groin
·         Abdominal pain or swelling
·         Chest pain, coughing or trouble breathing
·         Fatigue
·         Fever
·         Night sweats
·         Weight loss
 
Non-Hodgkin's lymphoma occurs when your body produces too many abnormal lymphocytes a type of white blood cell. Normally, lymphocytes go through a predictable life cycle. Old lymphocytes die, and your body creates new ones to replace them. In non-Hodgkin's lymphoma, your lymphocytes don't die, but continue to grow and divide. This oversupply of lymphocytes crowds into your lymph nodes, causing them to swell.
 
B cells and T cells
 
There are two types of lymphocytes, and non-Hodgkin's lymphoma usually involves one or the other.
 
B cells. B cells fight infection by producing antibodies that neutralize foreign invaders. Most non-Hodgkin's lymphoma arises from B cells. Subtypes of non-Hodgkin's lymphoma that involve B cells include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma and Burkitt lymphoma.
 
T cells. T cells are involved in killing foreign invaders directly. Non-Hodgkin's lymphoma occurs less often in T cells. Subtypes of non-Hodgkin's lymphoma that involve T cells include cutaneous T-cell lymphoma and anaplastic large cell lymphoma.
 
Non-Hodgkin's Lymphoma generally involves the presence of cancerous lymphocytes in your lymph nodes, but the disease can also spread to other parts of your lymphatic system. These include the lymphatic vessels, tonsils, adenoids, spleen, thymus and bone marrow. Occasionally, non-Hodgkin's lymphoma involves organs outside of your lymphatic system.
 

Treatment Method :

 
Number of Injection -   9 units of second generation umbilical cord blood DC-CIK cell (UCBDC-CIK)
 
Type of Injection -          
Intravenous (IV) Injection x 9 times 
 
Adjuvant Therapy :
 
Chinese traditional medicine to recuperate
 

Treatment Period :
 
9 days

 For more information on stem cell treatment for cancer immunotherapy, please complete a medical form here or visit http://hopestemcell.com/Free Medical Evaluation

 

 

International patients contact:

 

This email address is being protected from spambots. You need JavaScript enabled to view it.